CAR T-Cell Therapy

Cilta-Cel Treatment Safe, Effective for Relapsed/Refractory Multiple Myeloma

Blood Disorders

Cilta-Cel Treatment Safe, Effective for Relapsed/Refractory Multiple Myeloma

Oct 08, 2024

2 min read

Risk for Second Primary Cancer May Be
No Higher With CAR T-Cell Versus Standard of Care

Risk for Second Primary Cancer May Be No Higher With CAR T-Cell Versus Standard of Care

Sep 12, 2024

1 min read

Toxicities Rare After Two Weeks of CAR T-Cell Therapy Infusion

Blood Disorders

Toxicities Rare After Two Weeks of CAR T-Cell Therapy Infusion

Jul 30, 2024

1 min read

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

Jun 14, 2024

1 min read

Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients

Blood Disorders

Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients

Apr 25, 2024

1 min read

CD7 CAR T-Cell Therapy, Stem-Cell Transplant Beneficial for CD7-Positive Tumors

CD7 CAR T-Cell Therapy, Stem-Cell Transplant Beneficial for CD7-Positive Tumors

Apr 25, 2024

2 min read

FDA Approves Abecma for Relapsed, Refractory Multiple Myeloma

FDA Approves Abecma for Relapsed, Refractory Multiple Myeloma

Apr 09, 2024

2 min read

EEG Most Beneficial Tool for Managing CAR T-Cell-Related Neurotoxicity

Blood Disorders

EEG Most Beneficial Tool for Managing CAR T-Cell-Related Neurotoxicity

Apr 05, 2024

1 min read

CARv3-TEAM-E T-Cell Treatment Beneficial for Recurrent Glioblastoma

CARv3-TEAM-E T-Cell Treatment Beneficial for Recurrent Glioblastoma

Mar 21, 2024

1 min read

Read More

www.healthday.com